Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858 - Concepedia

Concepedia

Publication | Open Access

Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858

DOI Full Paper Access

63

Citations

23

References

2017

Year

Erika A. Eksioglu, X Chen, K-H Heider, Bjoern Rueter, Kathy L. McGraw, Ashley A. Basiorka, Ming-jie Wei, Angela D. Burnette, Pingyan Cheng, Jeffrey E. Lancet,

Health SciencesHematologyImmunologyLow Risk MdsBiological TherapyAntibody EngineeringImmunotherapyMedicineRadiation OncologyNovel Therapeutic Approach

References

	Year	Citations

Page 1

Page 1